Literature DB >> 11954772

Neuroprotective effects of propofol following global cerebral ischemia in rats.

Rüçhan Ergün1, Gökhan Akdemir, Sibel Sen, Alptekin Taşçi, Fikret Ergüngör.   

Abstract

Propofol has cerebral vascular and metabolic effects similar to those of barbiturates, and it is used to maintain neurosurgical anesthesia because it reduces cerebral metabolic rate, cerebral blood flow, and intracranial pressure. Although the use of propofol as a cerebral protectant during certain neurosurgical procedures has been advocated, consensus has not been reached as to a protective effect of propofol on cerebral ischemia. In this study we observed the neuroprotective effects of propofol during global cerebral ischemia-reperfusion injury by the use of four-vessel occlusion method in a rat model. We measured the levels of malondialdehyde as a marker of lipid peroxidation in ischemic tissue, and the results indicate that propofol plays a role in the inhibition of neuronal death induced by brain ischemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11954772     DOI: 10.1007/s101430100171

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  18 in total

1.  Propofol induces apoptosis and increases gemcitabine sensitivity in pancreatic cancer cells in vitro by inhibition of nuclear factor-κB activity.

Authors:  Qi-Hang Du; Yan-Bing Xu; Meng-Yuan Zhang; Peng Yun; Chang-Yao He
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 2.  Therapy of intracranial hypertension in patients with fulminant hepatic failure.

Authors:  Murugan Raghavan; Paul E Marik
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 3.  Propofol: a review of its role in pediatric anesthesia and sedation.

Authors:  Vidya Chidambaran; Andrew Costandi; Ajay D'Mello
Journal:  CNS Drugs       Date:  2015-07       Impact factor: 5.749

4.  Does propofol prevent testicular ischemia-reperfusion injury due to torsion in the long term?

Authors:  Ersoy Taşkara; Atilla Gör; Omer Kutlu; Ersagun Karagüzel; Umit Cobanoğlu; Murat Topbaş; Ahmet Can Senel
Journal:  Pediatr Surg Int       Date:  2011-04-06       Impact factor: 1.827

5.  The neuroprotective effect of propofol against brain ischemia mediated by the glutamatergic signaling pathway in rats.

Authors:  Jinsong Cai; Yuyan Hu; Wenbin Li; Li Li; Shuqin Li; Min Zhang; Qingjun Li
Journal:  Neurochem Res       Date:  2011-05-10       Impact factor: 3.996

6.  3,4-oxo-isopropylidene-shikimic acid inhibits cerebral ischemia-induced oxidative stress and neuronal apoptosis in rats.

Authors:  Ling-Ling Tang; Jing-Ya Ye; Sheng-Nan Jiang; Jie-Sheng Zheng
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

7.  Comparison of the effects of desflurane and propofol anesthesia on the inflammatory response and s100β protein during coronary artery bypass grafting.

Authors:  Elif Doğan Baki; Mustafa Aldemir; Serdar Kokulu; Halit Buğra Koca; Yüksel Ela; Remziye Gül Sıvacı; Nilgün Kavrut Öztürk; Mustafa Emmiler; Fahri Adalı; Hanife Uzel
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

Review 8.  The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties.

Authors:  Yoshinori Kotani; Masamitsu Shimazawa; Shinichi Yoshimura; Toru Iwama; Hideaki Hara
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

9.  Neuroprotective effects of propofol, thiopental, etomidate, and midazolam in fetal rat brain in ischemia-reperfusion model.

Authors:  Ferhat Harman; Askin Esen Hasturk; Mehmet Yaman; Turkan Arca; Kamer Kilinc; Mustafa Fevzi Sargon; Erkan Kaptanoglu
Journal:  Childs Nerv Syst       Date:  2012-05-05       Impact factor: 1.475

10.  Protective effects of intravenous anesthetics on kidney tissue in obstructive jaundice.

Authors:  Sinan Hatipoglu; Huseyin Yildiz; Ertan Bulbuloglu; Ismail Coskuner; Ergul Belge Kurutas; Filiz Hatipoglu; Harun Ciralik; Mehmet Sait Berhuni
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.